Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 18 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% 450.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $39.28 April 4th, 2014 • 18 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 6 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 7 PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% Mix Shift Highlights Specialty Transformation Page 8 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 64% 0% 20% 40% 80% 2005 2008 2010 2013 Q1 2014 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $60M Target 2015 Target Proof of Performance & 2015 Goals Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid single digit revenue CAGR Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 11 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 42.0% 2006 Q1 2014 Healthcare Consumer Packaging and Additive Technology Transportation Page 12 Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Investing in operational and initiatives that drive profitability growth Manufacturing realignment  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

GLS Thermoplastic Elastomer based impact modifier used to increase stiffness, lower weight and reduce cost for a storage tote

Garratt Senior Vice President, President of Performance Products and Solutions Walter Ripple General Manager of GLS Julie A. Patterson President and Chief Executive Officer PolyOne Corporation Page 27 Well Positioned for Revenue Growth Addressable Market by Platform $540 $215 $120 $40 $260 $525 ($ millions) Design/Service Sustainable Solutions Surface Modification Lightweighting Thermal Control Flame Retardancy $1.0 - $2.0 Billion of revenue generated from new products in 5 years Gross margin on new products exceed current gross margin by at least 10 percentage points World class vitality index of ≥ 35% 2018 PolyOne Corporation Page 28 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 29 2006 2013 Revenue ($ millions) Health and Wellness Evolution General purpose tubing TPE applications from GLS Specialty tubing Ergonomic enhancements Pre-certified biocompatible colorants Highly sophisticated catheter and drug delivery components Chemical and heat sterilizable materials Authentication and protection technologies Addressing wellness, prevention, diagnostic and therapy changes in healthcare setting Healthcare packaging solutions 2006 2015 & Beyond $416 $105 PolyOne Corporation Page 30 Transportation Evolution General purpose formulations (bumpers, roof racks) Long fiber for lightweighting Thermal management for LED lighting Thermoset composite pultrusions Conductive polymers for EMI shielding Formulations for aerospace interiors Thermoplastic composites High temperature formulations for aerospace Expand 3D printing capabilities 2006 2015 & Beyond 2006 2013 Revenue ($ millions) $709 $315 PolyOne Corporation Page 31 Packaging Evolution Masterbatch colors and PVC packaging materials TPEs to enhance brand appeal and consumer functionality Liquid color and additive technologies to extend shelf life, preserve taste and differentiate brands Leveraging color, additives and sheet technology for healthcare and consumer packaging solutions 2006 2015 & Beyond 2006 2013 Revenue ($ millions) $612 $260 PolyOne Corporation Page 32 Consumer Evolution Commodity plastic and masterbatch color solutions Engineered materials to enhance customer appeal through visual and performance improvements Formulated metal- to-polymer conversion to enhance performance and reduce manufacturing costs Biopolymers & composite materials leveraging unique color technology to build brand identity 2006 2015 & Beyond 2006 2013 Revenue ($ millions) $394 $228 PolyOne Corporation Page 33 Interactive Display Introduction PolyOne Corporation Page 34 Interactive Displays INNOVATION DISCUSSION LEADER TECHNOLOGIES MARKETS Polycast™ Bullet Resistant Sheet Aerospace GlasArmor™ Ballistic Resistant Panels Security reFlex™ Bio-Based Plasticizer Solutions Wilflex™ Oasis Hydrate InVisiO℠ Color Inspiration Forecast In-Store Audits OnColor™ Portfolio Light Weighting Thermal Management Corrosion Resistance Design Flexibility Sustainability Global Supply Chain Ergonomics and Aesthetics Consumer Appeal 9) Consumer Electronics Solutions Walter Ripple General Manager GLS Personal Electronics Wearable Electronics Hand Held Devices Portable Audio 7) Metal Replacement Technology Kurt Schuering Vice President Global Key Account Management Aerospace Sporting and Shooting 8) Medical Device Solutions Dr. Patterson President and Chief Executive Officer PolyOne Corporation Page 36 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 37 Innovation Drives Earnings Growth $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 PolyOne Corporation Page 38 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 39 Track Record of Successful Integrations and Rapid Operating Income Growth $12 $44 2007 2013 $22 $30 2012 2013 $24 $49 2012 2013 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 40 2015 and Beyond Innovation will drive the next stage in our remarkable transformation Deliver on 2015 goals Expand Specialty offerings and possibilities Identified as a truly global, specialty chemical company Market Potential Exceeds $40 Billion PolyOne Corporation Page 41 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 42% Sigma Aldrich 18% FMC 25% IFF 18% Eastman 17% Hexcel 16% 16% Rockwood Holdings Celanese 14% 7% EBIT Margin – 2013 Albemarle 24% Ecolab 13% PolyOne Corporation Page 42 Bright Future & High Aspirations – The Next Seven Years • % OP Income from Specialty - 5% • Market Cap - $500 Million • Revenue - $2.6 Billion • Commodity Peers • Specialty ROS - 1.5% • % OP Income from Specialty - 62% • Market Cap - $3.5 Billion • Revenue - $3.7 Billion • Specialty ROS - 9.4% • % OP Income from Specialty - 80 to 90% • Market Cap - $12 to $18 Billion • Revenue - $8 to $10 Billion • Specialty Peers • Specialty ROS - ≥ 20% 2000 – 2006 2007 – 2013 2014 – 2020 PolyOne Corporation Page 43 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

Overmolding of Thermoplastic Elastomers: Engineered solutions for consumer product differentiation Krishna Venkataswamy, Rajesh Varma and Walter Ripple, Thermoplastic Elastomers Division,GLS Corporation, 833, Ridgeview Drive, McHenry, IL 60050 Introduction Overmolding Thermoplastic Elastomers (TPEs) has come of age. The TPE compounds developed at GLS bridge the gap of the above chemistries and offer solutions to customers with adhesion requirements for substrates ranging from Polypropylene to Polyamide which represent the opposite spectrum of polarity. GLS Overmolding Guide, 2002 ook of Thermoplastic Elastomers, G.Holden, N.R.Legge, R.Quirk and H.E.Schroeder. 1979 .

Avient GLS thermoplastic elastomer (TPE) material specialists identified a current TPE within the OnFlex™ S HF, non-halogenated, flame retardant portfolio that could be slightly modified to meet the application’s requirements.

The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income and gross margin, adjusted operating income, free cash flow, return on invested capital, GLS operating income, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations.

Avon Lake, OH) containing ZPT (Lonza Group AG, Morristown, New Jersey) was formulated into select grades of Versaflex™ and OnFlex™ GLS™ TPEs. In the evaluation of ZPT-containing compounds, 34 distinct TPE formulations were produced, with each group being represented by various commercially active grades of Versaflex™ or OnFlex™ GLS™ elastomers. Figure 2 shows the performance of a select series of Versaflex™ and OnFlex™ GLS™ TPEs with a range of ZPT additive (1000–3000 ppm).

GLS™ OnFlex™ Thermoplastic Elastomers GLS™ OnFlex™ Thermoplastic Elastomers

GLS Thermoplastic Alloys GLS Thermoplastic Elastomers

GLS can provide special grades with internal mold release agents to minimize the problem. For assistance in optimizing your design, please contact your GLS Representative prior to cutting prototype or production tools.